One of our Ph.D. candidates, Joe Flores-Toro, will be presenting his final defense on Thursday, Oct. 24. His defense is called, “Targeting CCR2-Expressing Myeloid Cells to Overcome Immune Checkpoint Inhibitor Resistance in Glioma.” He has worked within the laboratory of Jeffrey Harrison, Ph.D.
